NanoBiotech Pharma has developed NanobacTX, a unique anti-aging therapy shown in clinical studies to be effective in reversing the #1 cause of aging: Microvascular disease and atherosclerosis. Lifelong development of Microvascular Disease eventually presents itself as  Atherosclerosis,  Coronary Artery Heart Disease, Adult-Onset Diabetes.

In clinical studies, 4-6 months treatment with NanobacTX showed marked improvement in Atherosclerosis, Coronary Artery Disease, adult-onset Diabetes.

4-6 months treatment with Urobac has been shown to be an effective therapy in the treatment of Benign prostatic hypertrophy (BPH), Polycystic kidney disease (PKD) and Chronic Prostatitis.

Our pioneering scientific & clinical research has been conducted by highly-respected researchers at Baylor, Mayo Clinic, Cleveland Clinic, NASA, Washington Hospital Medical Center, Scripps, Stanford, USC, UCSF and scores of other institutions Worldwide and continues today with the goal of curing many previously untreatable chronic diseases. 

At Nanobiotech our goal is curing disease, not just treating the symptoms.

We provide health solutions for patients and new clinical pathways for physicians worldwide.